Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome
ConclusionTG/HDL-C can identify IR in premenopausal women with and/without PCOS; diagnostic cut-points differ from those of men and postmenopausal women. HDL-C is an alternative predictor in women with PCOS. These simple metabolic markers, which are standardized between labs, inexpensive, and routinely measured, can be used to tailor lifestyle and medical int erventions to improve health outcomes in insulin-resistant premenopausal women.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Heart | Insulin | Obesity | Ovaries | Polycystic Ovary Syndrome | Women